• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Delayed contrast MR may predict rheumatoid arthritis

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 11
Volume 32
Issue 11

Delayed gadolinium enhancement during MR imaging of cartilage of the metacarpophalangeal joints in patients with rheumatoid arthritis is feasible at 3T and may help predict rheumatoid arthritis.

Delayed gadolinium enhancement during MR imaging of cartilage of the metacarpophalangeal joints in patients with rheumatoid arthritis is feasible at 3T and may help predict rheumatoid arthritis.

The procedure involves T1 mapping following intravenous contrast. Concentration of the contrast in cartilage is an indirect measure of glycosaminoglycan (GAG), a component of hyaline cartilage.

The absence of GAG during delayed-contrast MR may help assess cartilage degeneration in the morphologically normal-appearing second and third metacarpophalangeal joints in patients.

Phalangeal and metacarpal delayed-enhancement values in patients with rheumatoid arthritis were significantly lower than in control subjects, although joint thickness was comparable in both groups, according to the researchers. Cartilage damage is a common occurrence in rheumatoid arthritis patients, so imaging may help for diagnosis and treatment purposes (Radiol 2010;257:441-447).

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.